Experimental Netherton Syndrome Treatment Receives Rare Pediatric Disease Designation from FDA
source: pixabay.com

Experimental Netherton Syndrome Treatment Receives Rare Pediatric Disease Designation from FDA

According to a press release from LifeMax Laboratories, Inc., the Food and Drug Administration (FDA) has granted the Company's experimental Netherton syndrome drug LM-030 (licensed from Novartis) Rare Pediatric Disease…

Continue Reading Experimental Netherton Syndrome Treatment Receives Rare Pediatric Disease Designation from FDA

CRISPR Genome Editing and Stem Cell Technology Uncovered the Cause of the Baby’s Heart Disorder

  Tatiana Legkiy was only two months old when she was rushed to a hospital in San Francisco after an echocardiogram showed that her heart was malfunctioning. A recent article in…

Continue Reading CRISPR Genome Editing and Stem Cell Technology Uncovered the Cause of the Baby’s Heart Disorder

Doctors Are Unable to Diagnose Many Rare Diseases. Genome Sequencing is Changing That Scenario

After twenty-two years physician Huang Chun-jung finally learned why his vision and hearing have fallen to thirty percent of normalcy, thanks to research conducted by the National Health Research Institutes…

Continue Reading Doctors Are Unable to Diagnose Many Rare Diseases. Genome Sequencing is Changing That Scenario
Alberta Diabetes Institute to Study Use of Anti-Obesity Drug in Alström and Bardet-Biedl Patients
mcmurryjulie / Pixabay

Alberta Diabetes Institute to Study Use of Anti-Obesity Drug in Alström and Bardet-Biedl Patients

According to a publication from EurekAlert, a clinical trial of setmelanotide, an experimental anti-obesity drug, is set to begin soon at the Alberta Diabetes Institute (of the University of Alberta).…

Continue Reading Alberta Diabetes Institute to Study Use of Anti-Obesity Drug in Alström and Bardet-Biedl Patients
Possible Treatment for Homozygous Familial Hypercholesterolemia Earns Orphan Drug Designation
katicaj / Pixabay

Possible Treatment for Homozygous Familial Hypercholesterolemia Earns Orphan Drug Designation

According to a story from bloomberg.com, the drug development company Arrowhead Pharmaceuticals, Inc. recently announced that its experimental product candidate AR0-ANG3 has earned Orphan Drug designation from the US Food…

Continue Reading Possible Treatment for Homozygous Familial Hypercholesterolemia Earns Orphan Drug Designation
Antibodies: The Key to Fighting Sickle Cell Anemia? Approval Could be Just Months Away
kalhh / Pixabay

Antibodies: The Key to Fighting Sickle Cell Anemia? Approval Could be Just Months Away

According to a story from PMLive, the US Food and Drug Administration (FDA) has recently begun the priority review process for a new potential therapy from pharmaceutical behemoth Novartis. This…

Continue Reading Antibodies: The Key to Fighting Sickle Cell Anemia? Approval Could be Just Months Away

Huntsman Lab Research Team Discovers that Selinexor May Benefit Myelofibrosis Patients Who have No Other Curative Options

  Myelofibrosis (MF) comes under the heading of rare cancer. A recent article in Newswise, University of Utah, describes the disease as the failure of bone marrow to produce normal…

Continue Reading Huntsman Lab Research Team Discovers that Selinexor May Benefit Myelofibrosis Patients Who have No Other Curative Options

Are People With Chronic Kidney Disease Being Excluded From Clinical Trials and Access to New Therapies?

Major European and international kidney associations have joined in an awareness campaign to stress the urgent need to include patients with chronic kidney disease in clinical trials. In a recent…

Continue Reading Are People With Chronic Kidney Disease Being Excluded From Clinical Trials and Access to New Therapies?

Patients with Amyotrophic Lateral Sclerosis Can Now Change the TV Channel with Just Their Eyes

For rare disease patients who face physical disabilities, even seemingly simple tasks can pose extreme difficulties. For instance, changing the channel on the television. Comcast Corp. previously created a voice…

Continue Reading Patients with Amyotrophic Lateral Sclerosis Can Now Change the TV Channel with Just Their Eyes

Study Determines More Research is Needed Regarding the Effect of Body Weight on Juvenile Idiopathic Arthritis

The Study Juvenile idiopathic arthritis (JIA) is a rare disease that causes inflammation in the joints. It is of unknown origin and has no cure. Previous investigations in studies with…

Continue Reading Study Determines More Research is Needed Regarding the Effect of Body Weight on Juvenile Idiopathic Arthritis
FDA Grants Fast Track Designation to Diffuse Large B-Cell Lymphoma Drug Candidate
https://pixabay.com/en/thumbs-up-okay-good-well-done-2056022/

FDA Grants Fast Track Designation to Diffuse Large B-Cell Lymphoma Drug Candidate

According to a press release from the New Jersey-based biotechnology company Cellectar Biosciences, the Food and Drug Administration (FDA) has granted "Fast Track" designation to the Company's experimental diffuse large…

Continue Reading FDA Grants Fast Track Designation to Diffuse Large B-Cell Lymphoma Drug Candidate